U S Department of Health and Human Services Improving the health, safety and well-being of America
  CMS Home > Medicare > Medicare Coverage - General Information > Medicare Coverage Database > Indexes Home > National Coverage Determinations (NCDs) > View NCD

Medicare Coverage Database

NCD for Cytogenetic Studies (190.3)

Publication Number

100-3

Manual Section Number

190.3

Version Number

1

Effective Date of this Version

7/16/1998

Benefit Category

Diagnostic Tests (other)

Note: This may not be an exhaustive list of all applicable Medicare benefit categories for this item or service.

Item/Service Description

The term cytogenetic studies is used to describe the microscopic examination of the physical appearance of human chromosomes.

Indications and Limitations of Coverage

Medicare covers these tests when they are reasonable and necessary for the diagnosis or treatment of the following conditions:

  • Genetic disorders (e.g., mongolism) in a fetus; (See the Medicare Benefit Policy Chapter 15, "Covered Medical and Other Health Services," §20.1)
  • Failure of sexual development;
  • Chronic myelogenous leukemia;
  • Acute leukemias lymphoid (FAB L1-L3), myeloid (FAB M0-M7), and unclassified; or
  • Mylodysplasia
Transmittal Number

105

Revision History

05/1998 - Added two new covered uses for these studies: acute leukemia (lymphoid, myeloid, and unclassified) and myelodysplasia. Effective date 07/16/1998. (TN 105)



basket Add to basket  |  envelope icon - email Email this to a friend  |  new search New Search



Page Last Modified: 4/23/2009 7:26:58 AM

Help with File Formats and Plug-Ins

Submit Feedback





www2